CHORDC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.683000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.203200E-01
Normal-vs-Stage2
9.338200E-01
Normal-vs-Stage3
1.511360E-01
Normal-vs-Stage4
6.286000E-01
Stage1-vs-Stage2
9.020200E-01
Stage1-vs-Stage3
5.273900E-02
Stage1-vs-Stage4
6.722800E-01
Stage2-vs-Stage3
1.878350E-01
Stage2-vs-Stage4
6.433800E-01
Stage3-vs-Stage4
7.049900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.443400E-01
Normal-vs-AfricanAmerican
7.615400E-01
Normal-vs-Asian
4.530000E-01
Caucasian-vs-AfricanAmerican
7.857200E-01
Caucasian-vs-Asian
2.362200E-01
AfricanAmerican-vs-Asian
1.720420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.230800E-01
Normal-vs-Female
7.570200E-01
Male-vs-Female
5.088300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.227200E-01
Normal-vs-Age(41-60Yrs)
6.339400E-01
Normal-vs-Age(61-80Yrs)
8.119400E-01
Normal-vs-Age(81-100Yrs)
5.406600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.356000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.871400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.081000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.427840E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.650310E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.995800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.617600E-01
Normal-vs-Daily Drinker
4.777400E-01
Normal-vs-Weekly Drinker
9.557800E-01
Normal-vs-Occasional Drinker
8.176200E-01
Normal-vs-Social Drinker
9.330200E-01
Non Drinker-vs-Daily Drinker
4.885000E-01
Non Drinker-vs-Weekly Drinker
3.990800E-01
Non Drinker-vs-Occasional Drinker
2.935400E-01
Non Drinker-vs-Social Drinker
4.406600E-01
Daily Drinker-vs-Weekly Drinker
2.169200E-01
Daily Drinker-vs-Occasional Drinker
1.675990E-01
Daily Drinker-vs-Social Drinker
2.078600E-01
Weekly Drinker-vs-Occasional Drinker
7.144000E-01
Weekly Drinker-vs-Social Drinker
9.542000E-01
Occasional Drinker-vs-Social Drinker
7.528800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.032160E-01
Normal-vs-Grade 2
1.104600E-01
Normal-vs-Grade 3
4.410300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.101200E-01
Grade 1-vs-Grade 3
4.148600E-01
Grade 1-vs-Grade 4
1.032160E-01
Grade 2-vs-Grade 3
4.400400E-01
Grade 2-vs-Grade 4
1.104600E-01
Grade 3-vs-Grade 4
4.410300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.731800E-01
Normal-vs-NonDiabetic
9.974200E-01
Diabetic-vs-NonDiabetic
6.665800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.683800E-01
Normal-vs-NoPancreatitis
9.855800E-01
Pancreatitis-vs-NoPancreatitis
9.266400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.483600E-01
Normal-vs-N1
9.070400E-01
N0-vs-N1
2.736800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.034600E-01
Normal-vs-TP53-NonMutant
8.379400E-01
TP53-Mutant-vs-TP53-NonMutant
1.397990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
